DOI: 10.1038/6142. Improving enzymes for cancer gene therapy

Improving enzymes for cancer gene therapy

10.1038/6142

Crossref journal-article

Springer Science and Business Media LLC

Nature Biotechnology (297)

Bibliography

Encell, L. P., Landis, D. M., & Loeb, L. A. (1999). Improving enzymes for cancer gene therapy. Nature Biotechnology, 17(2), 143â147.

Authors 3

Lance P. Encell (first)
Daniel M. Landis (additional)
Lawrence A. Loeb (additional)

References 56 Referenced 56

Skandalis, A., Encell L.P., and Loeb L.A. 1997. Creating novel enzymes by applied molecular evolution. Chem. Biol. 4:889–898. (10.1016/S1074-5521(97)90297-0) / Chem. Biol. by A Skandalis (1997)
Loeb, L.A. 1991. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 51:3075–3079. / Cancer Res. by LA Loeb (1991)
Moolten, F.L. 1994. Drug sensitivity ("suicide") genes for selective cancer chemotherapy. Cancer Gene Ther. 1:279–287. / Cancer Gene Ther. by FL Moolten (1994)
Moolten, F.L., Wells, J.M., Heyman, R.A., and Evans, R.M. 1990. Lymphoma regression induced by gancyclovir in mice bearing a herpes thymidine kinase transgene. Hum. Gene Ther. 1:125–134. (10.1089/hum.1990.1.2-125) / Hum. Gene Ther. by FL Moolten (1990)
Dachs, G.U., Dougherty, G.J., Stratford, I.J., and Chaplin, D.J. 1997. Targeting gene therapy to cancer: a review. Oncol. Res. 9:313–325. / Oncol. Res. by GU Dachs (1997)
Brenner, M.K. 1998. Gene transfer and the treatment of childhood cancer. Cancer Invest. 16:269–278. (10.3109/07357909809039777) / Cancer Invest. by MK Brenner (1998)
Rosenberg, S.A. 1993. Newer approaches to cancer treatment—gene therapy of cancer, pp. 2598–2613, in Cancer: principles and practice of oncology, 4th ed. DeVita, V.T., Jr., Hellman S., and Rosenberg S.A. (eds.). J.B. Lippincott, Philadelphia, PA. / Cancer: principles and practice of oncology, 4th ed. by SA Rosenberg (1993)
Banerjee, D., Zhao, S.C., Li M.–X., Schweitzer, B.I., Mineishi, S., and Bertino, J.R. 1994. Gene therapy utilizing drug resistance genes: a review. Stem Cells 12:378–385. (10.1002/stem.5530120404) / Stem Cells by D Banerjee (1994)
Rafferty, J.A., Hickson, I., Chinnasamy, N., Lashford, L.S., Margison, G.P., Dexter, T.M. et al. 1996. Chemoprotection of normal tissues by transfer of drug resistance genes. Cancer Metastasis Rev. 15:365–383. (10.1007/BF00046348) / Cancer Metastasis Rev. by JA Rafferty (1996)
Elion, G.B. 1980. The chemotherapeutic exploitation of virus–specified enzymes. Adv. Enzyme. Regul. 18:53–66. (10.1016/0065-2571(80)90008-4) / Adv. Enzyme. Regul. by GB Elion (1980)
Culver, K.W., Ram, Z., Walbridge, S., Ishii, H., Oldfield, E.H., and Blaese, R.M. 1992. In vivo gene transfer with retroviral vector–producer cells for treatment of experimental brain tumors. Science 256:1550–1552. (10.1126/science.1317968) / Science by KW Culver (1992)
Black, M.E. and Loeb, L.A. 1993. Identification of important residues within the putative nucleoside binding site of HSV–1 thymidine kinase by random sequence selection: analysis of selected mutants in vitro. Biochemistry 32:11618–11626. (10.1021/bi00094a019) / Biochemistry by ME Black (1993)
Black, M.E., Newcomb, T.G., Wilson, H.–M.P., and Loeb, L.A. 1996. Creation of drug–specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy. Proc. Natl. Acad. Sci. USA 93:3525–3529. (10.1073/pnas.93.8.3525) / Proc. Natl. Acad. Sci. USA by ME Black (1996)
Pope, I.M., Poston, G.J., and Kinsella, A.R. 1997. The role of the bystander effect in suicide gene therapy. Eur. J. Cancer 33:1005–1016. (10.1016/S0959-8049(96)00483-2) / Eur. J. Cancer by IM Pope (1997)
Bi, W.L., Parysek, L.M., and Warnick, R. 1993. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum. Gene. Ther. 4:725–731. (10.1089/hum.1993.4.6-725) / Hum. Gene. Ther. by WL Bi (1993)
Maze, R., Carney, J.P., Kelley, M.R., Glassner, B.J., Williams, D.A., and Samson, L. 1996. Increasing DNA repair methyltransferase levels via bone marrow stem cell transduction rescues mice from the toxic effects of 1,3–bis(2–cloroethyl)–1–nitrosourea, a chemotherapeutic alkylating agent. Proc. Natl. Acad. Sci. USA 93:206–210. (10.1073/pnas.93.1.206) / Proc. Natl. Acad. Sci. USA by R Maze (1996)
Mickisch, G.H., Licht, T., Merlino, G.T., Gottesman, M.M., and Pastan, I. 1991. Chemotherapy and chemosensitization of transgenic mice which express the human multidrug resistance gene in bone marrow: efficacy, potency, and toxicity. Cancer Res. 51:5417–5424. / Cancer Res. by GH Mickisch (1991)
Pegg, A.E., Dolan, M.E., and Moschel, R.C. 1995. Structure, function and inhibition of O6–alkylguanine–DNA alkyltransferase. Prog. Nucleic Acid Res. 51:167–223. (10.1016/S0079-6603(08)60879-X) / Prog. Nucleic Acid Res. by AE Pegg (1995)
Christians, F.C. and Loeb, L.A. 1996. Novel human DNA alkyltransferases obtained by random substitution and genetic selection in bacteria. Proc. Natl. Acad. Sci. USA 93:6124–6128. (10.1073/pnas.93.12.6124) / Proc. Natl. Acad. Sci. USA by FC Christians (1996)
Christians, F.C., Dawson B.J., Coates, M.M., and Loeb, L.A. 1997. Creation of human alkyltransferases resistant to O6–benzylguanine. Cancer Res. 57:2007–2012. / Cancer Res. by FC Christians (1997)
Encell, L.P., Coates, M.M., and Loeb, L.A. 1998. Engineering human DNA alkyltranferases for gene therapy using random sequence mutagenesis. Cancer Res. 58:1013–1020. / Cancer Res. by LP Encell (1998)
Xu–Welliver, M., Kanugula, S., and Pegg, A.E. 1998. Isolation of human O6–alkylguanine–DNA alkyltransferase mutants highly resistant to inactivation by O6–benzylguanine. Cancer Res. 58:1936–1945. / Cancer Res. by M Xu–Welliver (1998)
Loktionova, N.A., Xu–Welliver, M., Crone, T., Kanugula, S., and Pegg, A.E. 1999. Mutant forms of O6–alkylguanine–DNA alkyltransfersae protect CHO cells from killing by BCNU plus O6–benzylguanine or O6–8–oxo–benzylguanine. Biochem. Pharmacol. In press.
Davis, B.M., Reese, J.S., Koc, O.N., Lee, K., Schupp, J.E., and Gerson, S.L. 1997. Selection for G156A O6–methylguanine DNA methyltransferase gene–transduced hematopoietic progenitors and protection from lethality in mice treated with O6–benzylguanine and 1,3–bis(2–chloroethyl)–1–nitrosourea. Cancer Res. 57:5093–5099. / Cancer Res. by BM Davis (1997)
Chinnasamy, N., Rafferty, J.A., Hickson, I., Lashford, L.S., Longhurst, S.J., Thatcher, N. et al. (1998) Chemoprotective gene transfer II: multilineage in vivo protection of haemopoiesis against the effects of an antitumour agent by expression of a mutant human O6–alkylguanine–DNA alkyltranferase. Gene Ther. 5:842–847. (10.1038/sj.gt.3300699) / Gene Ther. by N Chinnasamy (1998)
Rode, W., Scanlon, K.J., Moroson, B.A., and Bertino, J.R. 1980. Regulation of thymidylate synthetase in mouse leukemia cells (L1210). J. Biol. Chem. 255:1305–1311. (10.1016/S0021-9258(19)86030-1) / J. Biol. Chem. by W Rode (1980)
Harrap, K.R., Jackman, A.L., Newell, D.R., Taylor, G.A., Hughes, L.A., and Calvert, A.H. 1989. Thymidylate synthase: a target for anti–cancer drug design. Adv. Enzyme Regul. 29:161–179. (10.1016/0065-2571(89)90099-X) / Adv. Enzyme Regul. by KR Harrap (1989)
Santi, D.V. and Danenberg, P.V. 1984. Chemistry and biochemistry of folates, pp. 345–398, in Folates and pterins, Blakley, R.L. and Benkovic, S.J. (eds.). Wiley–Interscience, New York, NY. / Folates and pterins by DV Santi (1984)
Grem, J.L. 1990. Fluorinated pyrimidines, pp. 180–224, in Cancer chemotherapy: principles and practice, Chabner, B.A. and Collins, J.M. (eds.). J.B. Lippincott, Philadelphia, PA. / Cancer chemotherapy: principles and practice by JL Grem (1990)
Barbour, K.W., Berger, S.H., and Berger, F.G. 1990. A single amino acid substitution defines a naturally occurring genetic variant of human thymidylate synthase. Mol. Pharmacol. 37:515–518. / Mol. Pharmacol. by KW Barbour (1990)
Tong, Y., Liu–Chen, X., Erickan–Abali, E.A., Capiaux, G.M., Zhao, S., Banerjee, D. et al. 1998. Isolation and characterization of Thymitaq (AG337) and 5–fluoro–2–deoxyuridylate–resistant mutants of human thymidylate synthase from ethyl methanesulfonate–exposed human sarcoma HT1080 cells. J. Biol. Chem. 273:11611–11618. (10.1074/jbc.273.19.11611) / J. Biol. Chem. by Y Tong (1998)
Landis, D.M. and Loeb, L.A. 1998. Random sequence mutagenesis and resistance to 5–fluorouridine in human thymidylate synthases. J. Biol. Chem. 273:25809–25817. (10.1074/jbc.273.40.25809) / J. Biol. Chem. by DM Landis (1998)
Tong, Y., Liu–Chen, X., Ercikan–Abali, E.A., Zhao, S., Banerjee, D., Maley F. et al. 1998. Probing the folate–binding site of human thymidylate synthase by site–directed mutagenesis. J. Biol. Chem. 273:31209–31214. (10.1074/jbc.273.47.31209) / J. Biol. Chem. by Y Tong (1998)
Haber, D.A., Beverly, S.M., Kiely, M.L., and Schimke, R.T. 1981. Properties of an altered dihydrofolate reductase encoded by amplified genes in cultured mouse fibroblasts. J. Biol. Chem. 256:9501–9510. (10.1016/S0021-9258(19)68791-0) / J. Biol. Chem. by DA Haber (1981)
Srimatkandala, S., Schweitzer, B.I., Moroson, B.A., Dube, S., and Bertino, J.R. 1989. Amplification of a polymorphic dihydrofolate reductase gene expressing an enzyme with a decreased binding to MTX in a human colon carcinoma cell line HCT–8R4 resistant to this drug. J. Biol. Chem. 264:3524–3528. (10.1016/S0021-9258(18)94097-4) / J. Biol. Chem. by S Srimatkandala (1989)
McIvor, R.S. and Simonsen, C.C. 1990. Isolation and characterization of a variant dihydrofolate reductase cDNA from the methotrexate resistant murine L5178Y cells. Nucleic Acids Res. 18:7025–7032. (10.1093/nar/18.23.7025) / Nucleic Acids Res. by RS McIvor (1990)
Thillet, J., Absil, J., Stone, S.R., and Pictet, R. 1988. Site directed mutagenesis of mouse dihydrofolate reductase. J. Biol. Chem. 263:12500–12508. (10.1016/S0021-9258(18)37783-4) / J. Biol. Chem. by J Thillet (1988)
McIvor, R.S. 1996. Drug–resistant dihydrofolate reductases: generation, expression and therapeutic application. Bone Marrow Transplant. 18:S50–S54. / Bone Marrow Transplant. by RS McIvor (1996)
Ercikan–Abali, E.A., Mineishi, S., Tong, Y., Nakahara, S., Waltham, M.C., Banerjee, D. et al. 1996. Active site–directed double mutants of dihydrofolate reductase. Cancer Res. 56:4142–4145. / Cancer Res. by EA Ercikan–Abali (1996)
James, R.I., May, C., Vagt, M.D., Studebaker, R., and McIvor, R. 1997. Transgenic mice expressing the tyr22 variant of murine DHFR: protection of transgenic marrow transplant recipients from lethal doses of methotrexate. Exp. Hematol. 25:1286–1295. / Exp. Hematol. by RI James (1997)
Williams, D.A., Hsieh, K., DeSilva, A., and Mulligan, R.C. 1987. Protection of bone marrow transplant recipients from lethal doses of methotrexate by the generation of methotrexate resistant bone marrow. J. Exp. Med. 166:210–218. (10.1084/jem.166.1.210) / J. Exp. Med. by DA Williams (1987)
Zhao, S., Li, M.–X., Banerjee, D., Schweitzer, B.I., Gilboa, E., and Bertino, J.R. 1994. Long term protection of recipient mice from lethal doses of methotrexate by marrow infected with a double copy vector retrovirus containing a mutant dihydrofolate reductase. Cancer Gene Ther. 1:27–33. / Cancer Gene Ther. by S Zhao (1994)
Zhao, S.–C., Banerjee, D., Mineishi, S., and Bertino, J.R. 1997. Post–transplant methotrexate administration leads to improved curability of mice bearing a mammary tumor transplanted with marrow transduced with a mutant human dihydrofolate reductase cDNA. Hum. Gene Ther. 8:903–909. (10.1089/hum.1997.8.8-903) / Hum. Gene Ther. by S–C Zhao (1997)
Spencer, H.T., Sleep, S.E.H., Rehg, J.E., Blakley, R.L., and Sorrentino, B.P. 1996. A gene therapy strategy for making bone marrow cells resistant to Trimetrexate. Blood 87:2579–2587. (10.1182/blood.V87.6.2579.bloodjournal8762579) / Blood by HT Spencer (1996)
Mineishi, S., Nakahara, S., Takebe, N., Banerjee, D., Zhao, S., and Bertino, J.R. 1997. Co–expression of the herpes simplex virus thymidine kinase gene potentiates methotrexate resistance conferred by transfer of a mutated dihydrofolate reductase gene. Gene Ther. 4:570–576. (10.1038/sj.gt.3300439) / Gene Ther. by S Mineishi (1997)
Mineishi, S., Nakahara, S., Takebe, N., and Zhao, S. 1998. Purine Salvage rescue by xanthine–guanine phosphoribosyltransferase (XGPRT) potentiates methotrexate resistance conferred by transfer of a mutated dihydrofolate reductase gene. Cancer Gene Ther. 5:144–149. / Cancer Gene Ther. by S Mineishi (1998)
Gulick, A.M. and Fahl, W.E. 1995. Forced evolution of glutathione S–transferase to create a more efficient drug detoxification enzyme. Proc. Natl. Acad. Sci. USA 92:8140–8144. (10.1073/pnas.92.18.8140) / Proc. Natl. Acad. Sci. USA by AM Gulick (1995)
Horwitz, M.S. and Loeb, L.A. 1986. Promoters selected from random DNA sequences. Proc. Natl. Acad. Sci. USA 83:7405–7409. (10.1073/pnas.83.19.7405) / Proc. Natl. Acad. Sci. USA by MS Horwitz (1986)
Sweasy, J.B. and Loeb, L.A. 1993. Detection and characterization of mammalian DNA polymerase β mutants by functional complementation in Escherichia coli. Proc. Natl. Acad. Sci. USA 90:4626–4630. (10.1073/pnas.90.10.4626) / Proc. Natl. Acad. Sci. USA by JB Sweasy (1993)
Cadwell, R.C. and Joyce, G.F. 1994. Mutagenic PCR. PCR Meth. Appl., 3:S136–S140. (10.1101/gr.3.6.S136) / PCR Meth. Appl. by RC Cadwell (1994)
Stemmer, W.P.C. 1994. Rapid evolution of a protein in vitro by DNA shuffling. Nature 370:389–391. (10.1038/370389a0) / Nature by WPC Stemmer (1994)
Zhao, H. and Arnold, F.H. 1997. Functional and nonfunctional mutations distinguished by random recombination of homologous genes. Proc. Natl. Acad. Sci. USA 94:7997–8000. (10.1073/pnas.94.15.7997) / Proc. Natl. Acad. Sci. USA by H Zhao (1997)
Guengerich, F.P. 1995. Human cytochrome P450 enzymes, pp. 473–535, in Cytochrome P450: structure, mechanism, and biochemistry, 2nd ed. Ortiz de Montellano, P.R. (ed.). Plenum Press, New York, NY. (10.1007/978-1-4757-2391-5_14) / Cytochrome P450: structure, mechanism, and biochemistry, 2nd ed. by FP Guengerich (1995)
Kivisto, K.T., Kroemer, H.K., and Eichelbaum, M. 1995. The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions. Br. J. Clin. Pharmacol. 40:523–530. (10.1111/j.1365-2125.1995.tb05796.x) / Br. J. Clin. Pharmacol. by KT Kivisto (1995)
LeBlanc, G.A. and Waxman, D.J. 1989. Interaction of anticancer drugs with hepatic monooxygenase enzymes. Drug Metab. Rev. 20:395–439. (10.3109/03602538909103550) / Drug Metab. Rev. by GA LeBlanc (1989)
Chakravarti, D., Ibeanu, G.D., Tano, K., and Mitra S. 1991. Cloning and expression in Escherichia coli of a human cDNA encoding the DNA repair protein N–methylpurine–DNA glycosylase. J. Biol. Chem. 266:15710–15715. (10.1016/S0021-9258(18)98467-X) / J. Biol. Chem. by D Chakravarti (1991)

Dates

Type	When
Created	23 years, 1 month ago (July 26, 2002, 4:48 a.m.)
Deposited	2 years, 3 months ago (May 18, 2023, 3:30 p.m.)
Indexed	1 month ago (Aug. 2, 2025, 12:36 a.m.)
Issued	26 years, 7 months ago (Feb. 1, 1999)
Published	26 years, 7 months ago (Feb. 1, 1999)
Published Print	26 years, 7 months ago (Feb. 1, 1999)

Funders 0

None

BibTeX

@article{Encell_1999, title={Improving enzymes for cancer gene therapy}, volume={17}, ISSN={1546-1696}, url={http://dx.doi.org/10.1038/6142}, DOI={10.1038/6142}, number={2}, journal={Nature Biotechnology}, publisher={Springer Science and Business Media LLC}, author={Encell, Lance P. and Landis, Daniel M. and Loeb, Lawrence A.}, year={1999}, month=feb, pages={143–147} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        8,
        2
      ]
    ],
    "date-time": "2025-08-02T04:36:52Z",
    "timestamp": 1754109412264
  },
  "reference-count": 56,
  "publisher": "Springer Science and Business Media LLC",
  "issue": "2",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            1999,
            2,
            1
          ]
        ],
        "date-time": "1999-02-01T00:00:00Z",
        "timestamp": 917827200000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "http://www.springer.com/tdm"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        1999,
        2
      ]
    ]
  },
  "DOI": "10.1038/6142",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2002,
        7,
        26
      ]
    ],
    "date-time": "2002-07-26T08:48:26Z",
    "timestamp": 1027673306000
  },
  "page": "143-147",
  "source": "Crossref",
  "is-referenced-by-count": 56,
  "title": "Improving enzymes for cancer gene therapy",
  "prefix": "10.1038",
  "volume": "17",
  "author": [
    {
      "given": "Lance P.",
      "family": "Encell",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Daniel M.",
      "family": "Landis",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Lawrence A.",
      "family": "Loeb",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "297",
  "reference": [
    {
      "key": "BFnbt0299_143_CR1",
      "doi-asserted-by": "publisher",
      "first-page": "889",
      "DOI": "10.1016/S1074-5521(97)90297-0",
      "volume": "4",
      "author": "A Skandalis",
      "year": "1997",
      "unstructured": "Skandalis, A., Encell L.P., and Loeb L.A. 1997. Creating novel enzymes by applied molecular evolution. Chem. Biol. 4:889\u2013898.",
      "journal-title": "Chem. Biol."
    },
    {
      "key": "BFnbt0299_143_CR2",
      "first-page": "3075",
      "volume": "51",
      "author": "LA Loeb",
      "year": "1991",
      "unstructured": "Loeb, L.A. 1991. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 51:3075\u20133079.",
      "journal-title": "Cancer Res."
    },
    {
      "key": "BFnbt0299_143_CR3",
      "first-page": "279",
      "volume": "1",
      "author": "FL Moolten",
      "year": "1994",
      "unstructured": "Moolten, F.L. 1994. Drug sensitivity (\"suicide\") genes for selective cancer chemotherapy. Cancer Gene Ther. 1:279\u2013287.",
      "journal-title": "Cancer Gene Ther."
    },
    {
      "key": "BFnbt0299_143_CR4",
      "doi-asserted-by": "publisher",
      "first-page": "125",
      "DOI": "10.1089/hum.1990.1.2-125",
      "volume": "1",
      "author": "FL Moolten",
      "year": "1990",
      "unstructured": "Moolten, F.L., Wells, J.M., Heyman, R.A., and Evans, R.M. 1990. Lymphoma regression induced by gancyclovir in mice bearing a herpes thymidine kinase transgene. Hum. Gene Ther. 1:125\u2013134.",
      "journal-title": "Hum. Gene Ther."
    },
    {
      "key": "BFnbt0299_143_CR5",
      "first-page": "313",
      "volume": "9",
      "author": "GU Dachs",
      "year": "1997",
      "unstructured": "Dachs, G.U., Dougherty, G.J., Stratford, I.J., and Chaplin, D.J. 1997. Targeting gene therapy to cancer: a review. Oncol. Res. 9:313\u2013325.",
      "journal-title": "Oncol. Res."
    },
    {
      "key": "BFnbt0299_143_CR6",
      "doi-asserted-by": "publisher",
      "first-page": "269",
      "DOI": "10.3109/07357909809039777",
      "volume": "16",
      "author": "MK Brenner",
      "year": "1998",
      "unstructured": "Brenner, M.K. 1998. Gene transfer and the treatment of childhood cancer. Cancer Invest. 16:269\u2013278.",
      "journal-title": "Cancer Invest."
    },
    {
      "key": "BFnbt0299_143_CR7",
      "first-page": "2598",
      "volume-title": "Cancer: principles and practice of oncology, 4th ed.",
      "author": "SA Rosenberg",
      "year": "1993",
      "unstructured": "Rosenberg, S.A. 1993. Newer approaches to cancer treatment\u2014gene therapy of cancer, pp. 2598\u20132613, in Cancer: principles and practice of oncology, 4th ed. DeVita, V.T., Jr., Hellman S., and Rosenberg S.A. (eds.). J.B. Lippincott, Philadelphia, PA."
    },
    {
      "key": "BFnbt0299_143_CR8",
      "doi-asserted-by": "publisher",
      "first-page": "378",
      "DOI": "10.1002/stem.5530120404",
      "volume": "12",
      "author": "D Banerjee",
      "year": "1994",
      "unstructured": "Banerjee, D., Zhao, S.C., Li M.\u2013X., Schweitzer, B.I., Mineishi, S., and Bertino, J.R. 1994. Gene therapy utilizing drug resistance genes: a review. Stem Cells 12:378\u2013385.",
      "journal-title": "Stem Cells"
    },
    {
      "key": "BFnbt0299_143_CR9",
      "doi-asserted-by": "publisher",
      "first-page": "365",
      "DOI": "10.1007/BF00046348",
      "volume": "15",
      "author": "JA Rafferty",
      "year": "1996",
      "unstructured": "Rafferty, J.A., Hickson, I., Chinnasamy, N., Lashford, L.S., Margison, G.P., Dexter, T.M. et al. 1996. Chemoprotection of normal tissues by transfer of drug resistance genes. Cancer Metastasis Rev. 15:365\u2013383.",
      "journal-title": "Cancer Metastasis Rev."
    },
    {
      "key": "BFnbt0299_143_CR10",
      "doi-asserted-by": "publisher",
      "first-page": "53",
      "DOI": "10.1016/0065-2571(80)90008-4",
      "volume": "18",
      "author": "GB Elion",
      "year": "1980",
      "unstructured": "Elion, G.B. 1980. The chemotherapeutic exploitation of virus\u2013specified enzymes. Adv. Enzyme. Regul. 18:53\u201366.",
      "journal-title": "Adv. Enzyme. Regul."
    },
    {
      "key": "BFnbt0299_143_CR11",
      "doi-asserted-by": "publisher",
      "first-page": "1550",
      "DOI": "10.1126/science.1317968",
      "volume": "256",
      "author": "KW Culver",
      "year": "1992",
      "unstructured": "Culver, K.W., Ram, Z., Walbridge, S., Ishii, H., Oldfield, E.H., and Blaese, R.M. 1992. In vivo gene transfer with retroviral vector\u2013producer cells for treatment of experimental brain tumors. Science 256:1550\u20131552.",
      "journal-title": "Science"
    },
    {
      "key": "BFnbt0299_143_CR12",
      "doi-asserted-by": "publisher",
      "first-page": "11618",
      "DOI": "10.1021/bi00094a019",
      "volume": "32",
      "author": "ME Black",
      "year": "1993",
      "unstructured": "Black, M.E. and Loeb, L.A. 1993. Identification of important residues within the putative nucleoside binding site of HSV\u20131 thymidine kinase by random sequence selection: analysis of selected mutants in vitro. Biochemistry 32:11618\u201311626.",
      "journal-title": "Biochemistry"
    },
    {
      "key": "BFnbt0299_143_CR13",
      "doi-asserted-by": "publisher",
      "first-page": "3525",
      "DOI": "10.1073/pnas.93.8.3525",
      "volume": "93",
      "author": "ME Black",
      "year": "1996",
      "unstructured": "Black, M.E., Newcomb, T.G., Wilson, H.\u2013M.P., and Loeb, L.A. 1996. Creation of drug\u2013specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy. Proc. Natl. Acad. Sci. USA 93:3525\u20133529.",
      "journal-title": "Proc. Natl. Acad. Sci. USA"
    },
    {
      "key": "BFnbt0299_143_CR14",
      "doi-asserted-by": "publisher",
      "first-page": "1005",
      "DOI": "10.1016/S0959-8049(96)00483-2",
      "volume": "33",
      "author": "IM Pope",
      "year": "1997",
      "unstructured": "Pope, I.M., Poston, G.J., and Kinsella, A.R. 1997. The role of the bystander effect in suicide gene therapy. Eur. J. Cancer 33:1005\u20131016.",
      "journal-title": "Eur. J. Cancer"
    },
    {
      "key": "BFnbt0299_143_CR15",
      "doi-asserted-by": "publisher",
      "first-page": "725",
      "DOI": "10.1089/hum.1993.4.6-725",
      "volume": "4",
      "author": "WL Bi",
      "year": "1993",
      "unstructured": "Bi, W.L., Parysek, L.M., and Warnick, R. 1993. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum. Gene. Ther. 4:725\u2013731.",
      "journal-title": "Hum. Gene. Ther."
    },
    {
      "key": "BFnbt0299_143_CR16",
      "doi-asserted-by": "publisher",
      "first-page": "206",
      "DOI": "10.1073/pnas.93.1.206",
      "volume": "93",
      "author": "R Maze",
      "year": "1996",
      "unstructured": "Maze, R., Carney, J.P., Kelley, M.R., Glassner, B.J., Williams, D.A., and Samson, L. 1996. Increasing DNA repair methyltransferase levels via bone marrow stem cell transduction rescues mice from the toxic effects of 1,3\u2013bis(2\u2013cloroethyl)\u20131\u2013nitrosourea, a chemotherapeutic alkylating agent. Proc. Natl. Acad. Sci. USA 93:206\u2013210.",
      "journal-title": "Proc. Natl. Acad. Sci. USA"
    },
    {
      "key": "BFnbt0299_143_CR17",
      "first-page": "5417",
      "volume": "51",
      "author": "GH Mickisch",
      "year": "1991",
      "unstructured": "Mickisch, G.H., Licht, T., Merlino, G.T., Gottesman, M.M., and Pastan, I. 1991. Chemotherapy and chemosensitization of transgenic mice which express the human multidrug resistance gene in bone marrow: efficacy, potency, and toxicity. Cancer Res. 51:5417\u20135424.",
      "journal-title": "Cancer Res."
    },
    {
      "key": "BFnbt0299_143_CR18",
      "doi-asserted-by": "publisher",
      "first-page": "167",
      "DOI": "10.1016/S0079-6603(08)60879-X",
      "volume": "51",
      "author": "AE Pegg",
      "year": "1995",
      "unstructured": "Pegg, A.E., Dolan, M.E., and Moschel, R.C. 1995. Structure, function and inhibition of O6\u2013alkylguanine\u2013DNA alkyltransferase. Prog. Nucleic Acid Res. 51:167\u2013223.",
      "journal-title": "Prog. Nucleic Acid Res."
    },
    {
      "key": "BFnbt0299_143_CR19",
      "doi-asserted-by": "publisher",
      "first-page": "6124",
      "DOI": "10.1073/pnas.93.12.6124",
      "volume": "93",
      "author": "FC Christians",
      "year": "1996",
      "unstructured": "Christians, F.C. and Loeb, L.A. 1996. Novel human DNA alkyltransferases obtained by random substitution and genetic selection in bacteria. Proc. Natl. Acad. Sci. USA 93:6124\u20136128.",
      "journal-title": "Proc. Natl. Acad. Sci. USA"
    },
    {
      "key": "BFnbt0299_143_CR20",
      "first-page": "2007",
      "volume": "57",
      "author": "FC Christians",
      "year": "1997",
      "unstructured": "Christians, F.C., Dawson B.J., Coates, M.M., and Loeb, L.A. 1997. Creation of human alkyltransferases resistant to O6\u2013benzylguanine. Cancer Res. 57:2007\u20132012.",
      "journal-title": "Cancer Res."
    },
    {
      "key": "BFnbt0299_143_CR21",
      "first-page": "1013",
      "volume": "58",
      "author": "LP Encell",
      "year": "1998",
      "unstructured": "Encell, L.P., Coates, M.M., and Loeb, L.A. 1998. Engineering human DNA alkyltranferases for gene therapy using random sequence mutagenesis. Cancer Res. 58:1013\u20131020.",
      "journal-title": "Cancer Res."
    },
    {
      "key": "BFnbt0299_143_CR22",
      "first-page": "1936",
      "volume": "58",
      "author": "M Xu\u2013Welliver",
      "year": "1998",
      "unstructured": "Xu\u2013Welliver, M., Kanugula, S., and Pegg, A.E. 1998. Isolation of human O6\u2013alkylguanine\u2013DNA alkyltransferase mutants highly resistant to inactivation by O6\u2013benzylguanine. Cancer Res. 58:1936\u20131945.",
      "journal-title": "Cancer Res."
    },
    {
      "key": "BFnbt0299_143_CR23",
      "unstructured": "Loktionova, N.A., Xu\u2013Welliver, M., Crone, T., Kanugula, S., and Pegg, A.E. 1999. Mutant forms of O6\u2013alkylguanine\u2013DNA alkyltransfersae protect CHO cells from killing by BCNU plus O6\u2013benzylguanine or O6\u20138\u2013oxo\u2013benzylguanine. Biochem. Pharmacol. In press."
    },
    {
      "key": "BFnbt0299_143_CR24",
      "first-page": "5093",
      "volume": "57",
      "author": "BM Davis",
      "year": "1997",
      "unstructured": "Davis, B.M., Reese, J.S., Koc, O.N., Lee, K., Schupp, J.E., and Gerson, S.L. 1997. Selection for G156A O6\u2013methylguanine DNA methyltransferase gene\u2013transduced hematopoietic progenitors and protection from lethality in mice treated with O6\u2013benzylguanine and 1,3\u2013bis(2\u2013chloroethyl)\u20131\u2013nitrosourea. Cancer Res. 57:5093\u20135099.",
      "journal-title": "Cancer Res."
    },
    {
      "key": "BFnbt0299_143_CR25",
      "doi-asserted-by": "publisher",
      "first-page": "842",
      "DOI": "10.1038/sj.gt.3300699",
      "volume": "5",
      "author": "N Chinnasamy",
      "year": "1998",
      "unstructured": "Chinnasamy, N., Rafferty, J.A., Hickson, I., Lashford, L.S., Longhurst, S.J., Thatcher, N. et al. (1998) Chemoprotective gene transfer II: multilineage in vivo protection of haemopoiesis against the effects of an antitumour agent by expression of a mutant human O6\u2013alkylguanine\u2013DNA alkyltranferase. Gene Ther. 5:842\u2013847.",
      "journal-title": "Gene Ther."
    },
    {
      "key": "BFnbt0299_143_CR26",
      "doi-asserted-by": "crossref",
      "first-page": "1305",
      "DOI": "10.1016/S0021-9258(19)86030-1",
      "volume": "255",
      "author": "W Rode",
      "year": "1980",
      "unstructured": "Rode, W., Scanlon, K.J., Moroson, B.A., and Bertino, J.R. 1980. Regulation of thymidylate synthetase in mouse leukemia cells (L1210). J. Biol. Chem. 255:1305\u20131311.",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "BFnbt0299_143_CR27",
      "doi-asserted-by": "publisher",
      "first-page": "161",
      "DOI": "10.1016/0065-2571(89)90099-X",
      "volume": "29",
      "author": "KR Harrap",
      "year": "1989",
      "unstructured": "Harrap, K.R., Jackman, A.L., Newell, D.R., Taylor, G.A., Hughes, L.A., and Calvert, A.H. 1989. Thymidylate synthase: a target for anti\u2013cancer drug design. Adv. Enzyme Regul. 29:161\u2013179.",
      "journal-title": "Adv. Enzyme Regul."
    },
    {
      "key": "BFnbt0299_143_CR28",
      "first-page": "345",
      "volume-title": "Folates and pterins",
      "author": "DV Santi",
      "year": "1984",
      "unstructured": "Santi, D.V. and Danenberg, P.V. 1984. Chemistry and biochemistry of folates, pp. 345\u2013398, in Folates and pterins, Blakley, R.L. and Benkovic, S.J. (eds.). Wiley\u2013Interscience, New York, NY."
    },
    {
      "key": "BFnbt0299_143_CR29",
      "first-page": "180",
      "volume-title": "Cancer chemotherapy: principles and practice",
      "author": "JL Grem",
      "year": "1990",
      "unstructured": "Grem, J.L. 1990. Fluorinated pyrimidines, pp. 180\u2013224, in Cancer chemotherapy: principles and practice, Chabner, B.A. and Collins, J.M. (eds.). J.B. Lippincott, Philadelphia, PA."
    },
    {
      "key": "BFnbt0299_143_CR30",
      "first-page": "515",
      "volume": "37",
      "author": "KW Barbour",
      "year": "1990",
      "unstructured": "Barbour, K.W., Berger, S.H., and Berger, F.G. 1990. A single amino acid substitution defines a naturally occurring genetic variant of human thymidylate synthase. Mol. Pharmacol. 37:515\u2013518.",
      "journal-title": "Mol. Pharmacol."
    },
    {
      "key": "BFnbt0299_143_CR31",
      "doi-asserted-by": "publisher",
      "first-page": "11611",
      "DOI": "10.1074/jbc.273.19.11611",
      "volume": "273",
      "author": "Y Tong",
      "year": "1998",
      "unstructured": "Tong, Y., Liu\u2013Chen, X., Erickan\u2013Abali, E.A., Capiaux, G.M., Zhao, S., Banerjee, D. et al. 1998. Isolation and characterization of Thymitaq (AG337) and 5\u2013fluoro\u20132\u2013deoxyuridylate\u2013resistant mutants of human thymidylate synthase from ethyl methanesulfonate\u2013exposed human sarcoma HT1080 cells. J. Biol. Chem. 273:11611\u201311618.",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "BFnbt0299_143_CR32",
      "doi-asserted-by": "publisher",
      "first-page": "25809",
      "DOI": "10.1074/jbc.273.40.25809",
      "volume": "273",
      "author": "DM Landis",
      "year": "1998",
      "unstructured": "Landis, D.M. and Loeb, L.A. 1998. Random sequence mutagenesis and resistance to 5\u2013fluorouridine in human thymidylate synthases. J. Biol. Chem. 273:25809\u201325817.",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "BFnbt0299_143_CR33",
      "doi-asserted-by": "publisher",
      "first-page": "31209",
      "DOI": "10.1074/jbc.273.47.31209",
      "volume": "273",
      "author": "Y Tong",
      "year": "1998",
      "unstructured": "Tong, Y., Liu\u2013Chen, X., Ercikan\u2013Abali, E.A., Zhao, S., Banerjee, D., Maley F. et al. 1998. Probing the folate\u2013binding site of human thymidylate synthase by site\u2013directed mutagenesis. J. Biol. Chem. 273:31209\u201331214.",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "BFnbt0299_143_CR34",
      "doi-asserted-by": "crossref",
      "first-page": "9501",
      "DOI": "10.1016/S0021-9258(19)68791-0",
      "volume": "256",
      "author": "DA Haber",
      "year": "1981",
      "unstructured": "Haber, D.A., Beverly, S.M., Kiely, M.L., and Schimke, R.T. 1981. Properties of an altered dihydrofolate reductase encoded by amplified genes in cultured mouse fibroblasts. J. Biol. Chem. 256:9501\u20139510.",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "BFnbt0299_143_CR35",
      "doi-asserted-by": "crossref",
      "first-page": "3524",
      "DOI": "10.1016/S0021-9258(18)94097-4",
      "volume": "264",
      "author": "S Srimatkandala",
      "year": "1989",
      "unstructured": "Srimatkandala, S., Schweitzer, B.I., Moroson, B.A., Dube, S., and Bertino, J.R. 1989. Amplification of a polymorphic dihydrofolate reductase gene expressing an enzyme with a decreased binding to MTX in a human colon carcinoma cell line HCT\u20138R4 resistant to this drug. J. Biol. Chem. 264:3524\u20133528.",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "BFnbt0299_143_CR36",
      "doi-asserted-by": "publisher",
      "first-page": "7025",
      "DOI": "10.1093/nar/18.23.7025",
      "volume": "18",
      "author": "RS McIvor",
      "year": "1990",
      "unstructured": "McIvor, R.S. and Simonsen, C.C. 1990. Isolation and characterization of a variant dihydrofolate reductase cDNA from the methotrexate resistant murine L5178Y cells. Nucleic Acids Res. 18:7025\u20137032.",
      "journal-title": "Nucleic Acids Res."
    },
    {
      "key": "BFnbt0299_143_CR37",
      "doi-asserted-by": "crossref",
      "first-page": "12500",
      "DOI": "10.1016/S0021-9258(18)37783-4",
      "volume": "263",
      "author": "J Thillet",
      "year": "1988",
      "unstructured": "Thillet, J., Absil, J., Stone, S.R., and Pictet, R. 1988. Site directed mutagenesis of mouse dihydrofolate reductase. J. Biol. Chem. 263:12500\u201312508.",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "BFnbt0299_143_CR38",
      "first-page": "S50",
      "volume": "18",
      "author": "RS McIvor",
      "year": "1996",
      "unstructured": "McIvor, R.S. 1996. Drug\u2013resistant dihydrofolate reductases: generation, expression and therapeutic application. Bone Marrow Transplant. 18:S50\u2013S54.",
      "journal-title": "Bone Marrow Transplant."
    },
    {
      "key": "BFnbt0299_143_CR39",
      "first-page": "4142",
      "volume": "56",
      "author": "EA Ercikan\u2013Abali",
      "year": "1996",
      "unstructured": "Ercikan\u2013Abali, E.A., Mineishi, S., Tong, Y., Nakahara, S., Waltham, M.C., Banerjee, D. et al. 1996. Active site\u2013directed double mutants of dihydrofolate reductase. Cancer Res. 56:4142\u20134145.",
      "journal-title": "Cancer Res."
    },
    {
      "key": "BFnbt0299_143_CR40",
      "first-page": "1286",
      "volume": "25",
      "author": "RI James",
      "year": "1997",
      "unstructured": "James, R.I., May, C., Vagt, M.D., Studebaker, R., and McIvor, R. 1997. Transgenic mice expressing the tyr22 variant of murine DHFR: protection of transgenic marrow transplant recipients from lethal doses of methotrexate. Exp. Hematol. 25:1286\u20131295.",
      "journal-title": "Exp. Hematol."
    },
    {
      "key": "BFnbt0299_143_CR41",
      "doi-asserted-by": "publisher",
      "first-page": "210",
      "DOI": "10.1084/jem.166.1.210",
      "volume": "166",
      "author": "DA Williams",
      "year": "1987",
      "unstructured": "Williams, D.A., Hsieh, K., DeSilva, A., and Mulligan, R.C. 1987. Protection of bone marrow transplant recipients from lethal doses of methotrexate by the generation of methotrexate resistant bone marrow. J. Exp. Med. 166:210\u2013218.",
      "journal-title": "J. Exp. Med."
    },
    {
      "key": "BFnbt0299_143_CR42",
      "first-page": "27",
      "volume": "1",
      "author": "S Zhao",
      "year": "1994",
      "unstructured": "Zhao, S., Li, M.\u2013X., Banerjee, D., Schweitzer, B.I., Gilboa, E., and Bertino, J.R. 1994. Long term protection of recipient mice from lethal doses of methotrexate by marrow infected with a double copy vector retrovirus containing a mutant dihydrofolate reductase. Cancer Gene Ther. 1:27\u201333.",
      "journal-title": "Cancer Gene Ther."
    },
    {
      "key": "BFnbt0299_143_CR43",
      "doi-asserted-by": "publisher",
      "first-page": "903",
      "DOI": "10.1089/hum.1997.8.8-903",
      "volume": "8",
      "author": "S\u2013C Zhao",
      "year": "1997",
      "unstructured": "Zhao, S.\u2013C., Banerjee, D., Mineishi, S., and Bertino, J.R. 1997. Post\u2013transplant methotrexate administration leads to improved curability of mice bearing a mammary tumor transplanted with marrow transduced with a mutant human dihydrofolate reductase cDNA. Hum. Gene Ther. 8:903\u2013909.",
      "journal-title": "Hum. Gene Ther."
    },
    {
      "key": "BFnbt0299_143_CR44",
      "doi-asserted-by": "crossref",
      "first-page": "2579",
      "DOI": "10.1182/blood.V87.6.2579.bloodjournal8762579",
      "volume": "87",
      "author": "HT Spencer",
      "year": "1996",
      "unstructured": "Spencer, H.T., Sleep, S.E.H., Rehg, J.E., Blakley, R.L., and Sorrentino, B.P. 1996. A gene therapy strategy for making bone marrow cells resistant to Trimetrexate. Blood 87:2579\u20132587.",
      "journal-title": "Blood"
    },
    {
      "key": "BFnbt0299_143_CR45",
      "doi-asserted-by": "publisher",
      "first-page": "570",
      "DOI": "10.1038/sj.gt.3300439",
      "volume": "4",
      "author": "S Mineishi",
      "year": "1997",
      "unstructured": "Mineishi, S., Nakahara, S., Takebe, N., Banerjee, D., Zhao, S., and Bertino, J.R. 1997. Co\u2013expression of the herpes simplex virus thymidine kinase gene potentiates methotrexate resistance conferred by transfer of a mutated dihydrofolate reductase gene. Gene Ther. 4:570\u2013576.",
      "journal-title": "Gene Ther."
    },
    {
      "key": "BFnbt0299_143_CR46",
      "first-page": "144",
      "volume": "5",
      "author": "S Mineishi",
      "year": "1998",
      "unstructured": "Mineishi, S., Nakahara, S., Takebe, N., and Zhao, S. 1998. Purine Salvage rescue by xanthine\u2013guanine phosphoribosyltransferase (XGPRT) potentiates methotrexate resistance conferred by transfer of a mutated dihydrofolate reductase gene. Cancer Gene Ther. 5:144\u2013149.",
      "journal-title": "Cancer Gene Ther."
    },
    {
      "key": "BFnbt0299_143_CR47",
      "doi-asserted-by": "publisher",
      "first-page": "8140",
      "DOI": "10.1073/pnas.92.18.8140",
      "volume": "92",
      "author": "AM Gulick",
      "year": "1995",
      "unstructured": "Gulick, A.M. and Fahl, W.E. 1995. Forced evolution of glutathione S\u2013transferase to create a more efficient drug detoxification enzyme. Proc. Natl. Acad. Sci. USA 92:8140\u20138144.",
      "journal-title": "Proc. Natl. Acad. Sci. USA"
    },
    {
      "key": "BFnbt0299_143_CR48",
      "doi-asserted-by": "publisher",
      "first-page": "7405",
      "DOI": "10.1073/pnas.83.19.7405",
      "volume": "83",
      "author": "MS Horwitz",
      "year": "1986",
      "unstructured": "Horwitz, M.S. and Loeb, L.A. 1986. Promoters selected from random DNA sequences. Proc. Natl. Acad. Sci. USA 83:7405\u20137409.",
      "journal-title": "Proc. Natl. Acad. Sci. USA"
    },
    {
      "key": "BFnbt0299_143_CR49",
      "doi-asserted-by": "publisher",
      "first-page": "4626",
      "DOI": "10.1073/pnas.90.10.4626",
      "volume": "90",
      "author": "JB Sweasy",
      "year": "1993",
      "unstructured": "Sweasy, J.B. and Loeb, L.A. 1993. Detection and characterization of mammalian DNA polymerase \u03b2 mutants by functional complementation in Escherichia coli. Proc. Natl. Acad. Sci. USA 90:4626\u20134630.",
      "journal-title": "Proc. Natl. Acad. Sci. USA"
    },
    {
      "key": "BFnbt0299_143_CR50",
      "doi-asserted-by": "publisher",
      "first-page": "S136",
      "DOI": "10.1101/gr.3.6.S136",
      "volume": "3",
      "author": "RC Cadwell",
      "year": "1994",
      "unstructured": "Cadwell, R.C. and Joyce, G.F. 1994. Mutagenic PCR. PCR Meth. Appl., 3:S136\u2013S140.",
      "journal-title": "PCR Meth. Appl."
    },
    {
      "key": "BFnbt0299_143_CR51",
      "doi-asserted-by": "publisher",
      "first-page": "389",
      "DOI": "10.1038/370389a0",
      "volume": "370",
      "author": "WPC Stemmer",
      "year": "1994",
      "unstructured": "Stemmer, W.P.C. 1994. Rapid evolution of a protein in vitro by DNA shuffling. Nature 370:389\u2013391.",
      "journal-title": "Nature"
    },
    {
      "key": "BFnbt0299_143_CR52",
      "doi-asserted-by": "publisher",
      "first-page": "7997",
      "DOI": "10.1073/pnas.94.15.7997",
      "volume": "94",
      "author": "H Zhao",
      "year": "1997",
      "unstructured": "Zhao, H. and Arnold, F.H. 1997. Functional and nonfunctional mutations distinguished by random recombination of homologous genes. Proc. Natl. Acad. Sci. USA 94:7997\u20138000.",
      "journal-title": "Proc. Natl. Acad. Sci. USA"
    },
    {
      "key": "BFnbt0299_143_CR53",
      "doi-asserted-by": "publisher",
      "first-page": "473",
      "DOI": "10.1007/978-1-4757-2391-5_14",
      "volume-title": "Cytochrome P450: structure, mechanism, and biochemistry, 2nd ed.",
      "author": "FP Guengerich",
      "year": "1995",
      "unstructured": "Guengerich, F.P. 1995. Human cytochrome P450 enzymes, pp. 473\u2013535, in Cytochrome P450: structure, mechanism, and biochemistry, 2nd ed. Ortiz de Montellano, P.R. (ed.). Plenum Press, New York, NY."
    },
    {
      "key": "BFnbt0299_143_CR54",
      "doi-asserted-by": "publisher",
      "first-page": "523",
      "DOI": "10.1111/j.1365-2125.1995.tb05796.x",
      "volume": "40",
      "author": "KT Kivisto",
      "year": "1995",
      "unstructured": "Kivisto, K.T., Kroemer, H.K., and Eichelbaum, M. 1995. The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions. Br. J. Clin. Pharmacol. 40:523\u2013530.",
      "journal-title": "Br. J. Clin. Pharmacol."
    },
    {
      "key": "BFnbt0299_143_CR55",
      "doi-asserted-by": "publisher",
      "first-page": "395",
      "DOI": "10.3109/03602538909103550",
      "volume": "20",
      "author": "GA LeBlanc",
      "year": "1989",
      "unstructured": "LeBlanc, G.A. and Waxman, D.J. 1989. Interaction of anticancer drugs with hepatic monooxygenase enzymes. Drug Metab. Rev. 20:395\u2013439.",
      "journal-title": "Drug Metab. Rev."
    },
    {
      "key": "BFnbt0299_143_CR56",
      "doi-asserted-by": "crossref",
      "first-page": "15710",
      "DOI": "10.1016/S0021-9258(18)98467-X",
      "volume": "266",
      "author": "D Chakravarti",
      "year": "1991",
      "unstructured": "Chakravarti, D., Ibeanu, G.D., Tano, K., and Mitra S. 1991. Cloning and expression in Escherichia coli of a human cDNA encoding the DNA repair protein N\u2013methylpurine\u2013DNA glycosylase. J. Biol. Chem. 266:15710\u201315715.",
      "journal-title": "J. Biol. Chem."
    }
  ],
  "container-title": "Nature Biotechnology",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "http://www.nature.com/articles/nbt0299_143.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/nbt0299_143",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/nbt0299_143.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        18
      ]
    ],
    "date-time": "2023-05-18T19:30:35Z",
    "timestamp": 1684438235000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/nbt0299_143"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        1999,
        2
      ]
    ]
  },
  "references-count": 56,
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          1999,
          2
        ]
      ]
    }
  },
  "alternative-id": [
    "BFnbt0299_143"
  ],
  "URL": "http://dx.doi.org/10.1038/6142",
  "relation": {},
  "ISSN": [
    "1087-0156",
    "1546-1696"
  ],
  "subject": [],
  "container-title-short": "Nat Biotechnol",
  "published": {
    "date-parts": [
      [
        1999,
        2
      ]
    ]
  }
}